_id
69130dc5ccc777a4e85d7d81
Ticker
LEXXW
Name
Lexaria Bioscience Corp
Exchange
NASDAQ
Address
740 McCurdy Road, Kelowna, BC, Canada, V1X 2P7
Country
USA
Sector
Industry
Currency
USD
Website
https://lexariabioscience.com
Description
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. Its DehydraTECH is used with a range of active molecules, including glucagon-like peptide-1 drugs (GLP-1) and glucose -dependent insulinotropic polypeptide drugs (GIP), vitamins, pain medications, hormones, phosphodiesterase type 5 (PDE5) inhibitors, antivirals, nicotine and its analogs, and cannabinoids. The company's DehydraTECH technology is applied to various therapeutic indications, such as diabetes, weight loss, hypertension, epilepsy, and heart disease; is implemented in a multitude of ingestible or topically administered product formats comprising oral suspensions, tablets, capsules, foods, beverages, and oral products; and is suitable for a variety of product formats, including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
Last Close
0.0099
Volume
8199
Current Price
0.0051
Change
0.0049
Last Updated
2026-01-04T16:26:50.263Z
Image
data:image/webp;base64,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
Ipo Date
2021-01-12T00:00:00.000Z
Market Cap
33790680
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-08-31
Revenue
174000
Cost Of Revenue
0
Gross Profit
174000
Operating Expenses
2862597
Operating Income
-2688597
Interest Expense
-
Pretax Income
-2697228
Net Income
-2695838
Eps
-0.13782981381784992
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-
Operating Margin
-1545.1706896551725
Total Other Income Expense Net
-11447
Cash
1802123
Short Term Investments
165360
Receivables
-
Inventories
-
Total Current Assets
3468345
Property Plant Equipment
334945
Total Assets
4175121
Payables
1365044
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1572366
Equity
2989697
Bs_currency_symbol
USD
Depreciation
21398
Change In Working Capital
-323932
Cash From Operations
-2642498
Capital Expenditures
14611
Cash From Investing
-
Cash From Financing
0
Net Change In Cash
-2789638
Cf_currency_symbol
USD
PE
-
PB
0.03336519148930477
ROE
-90.17094374446641
ROA
-64.56909871594141
FCF
-2657109
Fcf Percent
-15.270741379310344
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
4.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
1
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
6
Quarters > 0 > quarter
2025-08-31
Quarters > 0 > income Statement > revenue
174000
Quarters > 0 > income Statement > cost Of Revenue
0
Quarters > 0 > income Statement > gross Profit
174000
Quarters > 0 > income Statement > operating Expenses
2862597
Quarters > 0 > income Statement > operating Income
-2688597
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-2697228
Quarters > 0 > income Statement > net Income
-2695838
Quarters > 0 > income Statement > eps
-0.13782981381784992
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
19559179
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-1545.1706896551725
Quarters > 0 > income Statement > total Other Income Expense Net
-11447
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1802123
Quarters > 0 > balance Sheet > short Term Investments
165360
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
3468345
Quarters > 0 > balance Sheet > property Plant Equipment
334945
Quarters > 0 > balance Sheet > total Assets
4175121
Quarters > 0 > balance Sheet > payables
1365044
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1572366
Quarters > 0 > balance Sheet > equity
2989697
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2695838
Quarters > 0 > cash Flow > depreciation
21398
Quarters > 0 > cash Flow > change In Working Capital
-323932
Quarters > 0 > cash Flow > cash From Operations
-2642498
Quarters > 0 > cash Flow > capital Expenditures
14611
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-2789638
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.13782981381784992
Quarters > 0 > ratios > PB
0.03336519148930477
Quarters > 0 > ratios > ROE
-90.17094374446641
Quarters > 0 > ratios > ROA
-64.56909871594141
Quarters > 0 > ratios > FCF
-2657109
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-15.270741379310344
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2025-05-31
Quarters > 1 > income Statement > revenue
174000
Quarters > 1 > income Statement > cost Of Revenue
0
Quarters > 1 > income Statement > gross Profit
174000
Quarters > 1 > income Statement > operating Expenses
3924421
Quarters > 1 > income Statement > operating Income
-3750421
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-3790606
Quarters > 1 > income Statement > net Income
-3789092
Quarters > 1 > income Statement > eps
-0.2070733421323249
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
18298309
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-3719466
Quarters > 1 > income Statement > operating Margin
-2155.4143678160917
Quarters > 1 > income Statement > total Other Income Expense Net
-40185
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
4591761
Quarters > 1 > balance Sheet > short Term Investments
33540
Quarters > 1 > balance Sheet > receivables
358129
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
5806778
Quarters > 1 > balance Sheet > property Plant Equipment
354154
Quarters > 1 > balance Sheet > total Assets
6741366
Quarters > 1 > balance Sheet > payables
1446909
Quarters > 1 > balance Sheet > short Term Debt
29872
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1574845
Quarters > 1 > balance Sheet > equity
5552073
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-3790606
Quarters > 1 > cash Flow > depreciation
30955
Quarters > 1 > cash Flow > change In Working Capital
-344081
Quarters > 1 > cash Flow > cash From Operations
-3583953
Quarters > 1 > cash Flow > capital Expenditures
19443
Quarters > 1 > cash Flow > cash From Investing
-19443
Quarters > 1 > cash Flow > cash From Financing
1689050
Quarters > 1 > cash Flow > net Change In Cash
-1877173
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.2070733421323249
Quarters > 1 > ratios > PB
0.01680838416569811
Quarters > 1 > ratios > ROE
-68.24643696147366
Quarters > 1 > ratios > ROA
-56.206590771069244
Quarters > 1 > ratios > FCF
-3603396
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-20.7091724137931
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2025-02-28
Quarters > 2 > income Statement > revenue
174000
Quarters > 2 > income Statement > cost Of Revenue
0
Quarters > 2 > income Statement > gross Profit
174000
Quarters > 2 > income Statement > operating Expenses
2925012
Quarters > 2 > income Statement > operating Income
-2751012
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-2713212
Quarters > 2 > income Statement > net Income
-2713212
Quarters > 2 > income Statement > eps
-0.15493525891067952
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
17511908
Quarters > 2 > income Statement > income Tax Expense
3760
Quarters > 2 > income Statement > EBITDA
-2748735
Quarters > 2 > income Statement > operating Margin
-1581.0413793103448
Quarters > 2 > income Statement > total Other Income Expense Net
34040
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
6468934
Quarters > 2 > balance Sheet > short Term Investments
73915
Quarters > 2 > balance Sheet > receivables
331166
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
7724402
Quarters > 2 > balance Sheet > property Plant Equipment
358329
Quarters > 2 > balance Sheet > total Assets
8677570
Quarters > 2 > balance Sheet > payables
1278654
Quarters > 2 > balance Sheet > short Term Debt
29337
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1916802
Quarters > 2 > balance Sheet > equity
7144806
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2716972
Quarters > 2 > cash Flow > depreciation
2277
Quarters > 2 > cash Flow > change In Working Capital
168143
Quarters > 2 > cash Flow > cash From Operations
-1497891
Quarters > 2 > cash Flow > capital Expenditures
27894
Quarters > 2 > cash Flow > cash From Investing
-27894
Quarters > 2 > cash Flow > cash From Financing
11720
Quarters > 2 > cash Flow > net Change In Cash
-1609320
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.15493525891067952
Quarters > 2 > ratios > PB
0.012500091786956848
Quarters > 2 > ratios > ROE
-37.97460700822388
Quarters > 2 > ratios > ROA
-31.266956071803513
Quarters > 2 > ratios > FCF
-1525785
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-8.768879310344827
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-11-30
Quarters > 3 > income Statement > revenue
183923
Quarters > 3 > income Statement > cost Of Revenue
2720
Quarters > 3 > income Statement > gross Profit
181203
Quarters > 3 > income Statement > operating Expenses
2871910
Quarters > 3 > income Statement > operating Income
-2690707
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-2703699
Quarters > 3 > income Statement > net Income
-2703699
Quarters > 3 > income Statement > eps
-0.16220397104408774
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
16668513
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-2657512
Quarters > 3 > income Statement > operating Margin
-1462.9529748862296
Quarters > 3 > income Statement > total Other Income Expense Net
-12992
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
8078254
Quarters > 3 > balance Sheet > short Term Investments
39875
Quarters > 3 > balance Sheet > receivables
263491
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
8825741
Quarters > 3 > balance Sheet > property Plant Equipment
398646
Quarters > 3 > balance Sheet > total Assets
9793774
Quarters > 3 > balance Sheet > payables
262094
Quarters > 3 > balance Sheet > short Term Debt
57624
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
399718
Quarters > 3 > balance Sheet > equity
9774334
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2706628
Quarters > 3 > cash Flow > depreciation
33195
Quarters > 3 > cash Flow > change In Working Capital
-168143
Quarters > 3 > cash Flow > cash From Operations
-2726045
Quarters > 3 > cash Flow > capital Expenditures
24645
Quarters > 3 > cash Flow > cash From Investing
-37804
Quarters > 3 > cash Flow > cash From Financing
4345393
Quarters > 3 > cash Flow > net Change In Cash
1578369
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.16220397104408774
Quarters > 3 > ratios > PB
0.008697208045069875
Quarters > 3 > ratios > ROE
-27.66120944915531
Quarters > 3 > ratios > ROA
-27.60630375991931
Quarters > 3 > ratios > FCF
-2750690
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-14.955660792831782
Quarters > 3 > health Score
33
Annuals > 0 > quarter
2025-08-31
Annuals > 0 > income Statement > revenue
705923
Annuals > 0 > income Statement > cost Of Revenue
2720
Annuals > 0 > income Statement > gross Profit
703203
Annuals > 0 > income Statement > operating Expenses
12583940
Annuals > 0 > income Statement > operating Income
-11880737
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-11901841
Annuals > 0 > income Statement > net Income
-11901841
Annuals > 0 > income Statement > eps
-0.661260595548071
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
17998715
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-11880737
Annuals > 0 > income Statement > operating Margin
-1683.0074951517374
Annuals > 0 > income Statement > total Other Income Expense Net
-21104
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1802123
Annuals > 0 > balance Sheet > short Term Investments
143267
Annuals > 0 > balance Sheet > receivables
368358
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
3468345
Annuals > 0 > balance Sheet > property Plant Equipment
414634
Annuals > 0 > balance Sheet > total Assets
4175121
Annuals > 0 > balance Sheet > payables
1365044
Annuals > 0 > balance Sheet > short Term Debt
30417
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1572366
Annuals > 0 > balance Sheet > equity
2989697
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-11911434
Annuals > 0 > cash Flow > depreciation
87825
Annuals > 0 > cash Flow > change In Working Capital
195576
Annuals > 0 > cash Flow > cash From Operations
-10450387
Annuals > 0 > cash Flow > capital Expenditures
99752
Annuals > 0 > cash Flow > cash From Investing
-243019
Annuals > 0 > cash Flow > cash From Financing
6046163
Annuals > 0 > cash Flow > net Change In Cash
-4697762
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.661260595548071
Annuals > 0 > ratios > PB
0.054784249541006996
Annuals > 0 > ratios > ROE
-398.0952250345102
Annuals > 0 > ratios > ROA
-285.0657741416357
Annuals > 0 > ratios > FCF
-10550139
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-14.9451696573139
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2024-08-31
Annuals > 1 > income Statement > revenue
464278
Annuals > 1 > income Statement > cost Of Revenue
4822
Annuals > 1 > income Statement > gross Profit
459456
Annuals > 1 > income Statement > operating Expenses
6212586
Annuals > 1 > income Statement > operating Income
-5753130
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-5808654
Annuals > 1 > income Statement > net Income
-5795345
Annuals > 1 > income Statement > eps
-0.46797134748506414
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
12383974
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-5676977
Annuals > 1 > income Statement > operating Margin
-1239.1562813659057
Annuals > 1 > income Statement > total Other Income Expense Net
-55524
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
6499885
Annuals > 1 > balance Sheet > short Term Investments
55807
Annuals > 1 > balance Sheet > receivables
154477
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
7897986
Annuals > 1 > balance Sheet > property Plant Equipment
389552
Annuals > 1 > balance Sheet > total Assets
8867789
Annuals > 1 > balance Sheet > payables
371354
Annuals > 1 > balance Sheet > short Term Debt
28047
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1208738
Annuals > 1 > balance Sheet > equity
8036400
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-5808654
Annuals > 1 > cash Flow > depreciation
76153
Annuals > 1 > cash Flow > change In Working Capital
106556
Annuals > 1 > cash Flow > cash From Operations
-4959003
Annuals > 1 > cash Flow > capital Expenditures
43017
Annuals > 1 > cash Flow > cash From Investing
-188605
Annuals > 1 > cash Flow > cash From Financing
10315207
Annuals > 1 > cash Flow > net Change In Cash
5147783
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.46797134748506414
Annuals > 1 > ratios > PB
0.014022965930018418
Annuals > 1 > ratios > ROE
-72.1136951868996
Annuals > 1 > ratios > ROA
-65.35276155082175
Annuals > 1 > ratios > FCF
-5002020
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-10.773760548636808
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2023-08-31
Annuals > 2 > income Statement > revenue
226208
Annuals > 2 > income Statement > cost Of Revenue
31500
Annuals > 2 > income Statement > gross Profit
194708
Annuals > 2 > income Statement > operating Expenses
6728730
Annuals > 2 > income Statement > operating Income
-6534022
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-6712525
Annuals > 2 > income Statement > net Income
-6664899
Annuals > 2 > income Statement > eps
-1.0076855900742447
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
6614066
Annuals > 2 > income Statement > income Tax Expense
130877
Annuals > 2 > income Statement > EBITDA
-6388625
Annuals > 2 > income Statement > operating Margin
-2888.501732918376
Annuals > 2 > income Statement > total Other Income Expense Net
-178503
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
1352102
Annuals > 2 > balance Sheet > short Term Investments
125642
Annuals > 2 > balance Sheet > receivables
175245
Annuals > 2 > balance Sheet > inventories
1
Annuals > 2 > balance Sheet > total Current Assets
2199772
Annuals > 2 > balance Sheet > property Plant Equipment
421589
Annuals > 2 > balance Sheet > total Assets
3083986
Annuals > 2 > balance Sheet > payables
225038
Annuals > 2 > balance Sheet > short Term Debt
27794
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
403908
Annuals > 2 > balance Sheet > equity
3044118
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-6712525
Annuals > 2 > cash Flow > depreciation
145397
Annuals > 2 > cash Flow > change In Working Capital
143264
Annuals > 2 > cash Flow > cash From Operations
-5881237
Annuals > 2 > cash Flow > capital Expenditures
169610
Annuals > 2 > cash Flow > cash From Investing
-169610
Annuals > 2 > cash Flow > cash From Financing
1589731
Annuals > 2 > cash Flow > net Change In Cash
-4461116
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.0076855900742447
Annuals > 2 > ratios > PB
0.019771901286349612
Annuals > 2 > ratios > ROE
-218.94351664422996
Annuals > 2 > ratios > ROA
-216.11314059142939
Annuals > 2 > ratios > FCF
-6050847
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-26.749040705898995
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2022-08-31
Annuals > 3 > income Statement > revenue
255397
Annuals > 3 > income Statement > cost Of Revenue
71841
Annuals > 3 > income Statement > gross Profit
183556
Annuals > 3 > income Statement > operating Expenses
7567209
Annuals > 3 > income Statement > operating Income
-6619039
Annuals > 3 > income Statement > interest Expense
114329
Annuals > 3 > income Statement > pretax Income
-7383653
Annuals > 3 > income Statement > net Income
-7269324
Annuals > 3 > income Statement > eps
-1.2351778048322541
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
5885245
Annuals > 3 > income Statement > income Tax Expense
-114329
Annuals > 3 > income Statement > EBITDA
-6516321
Annuals > 3 > income Statement > operating Margin
-2591.666699295606
Annuals > 3 > income Statement > total Other Income Expense Net
-764614
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
5813218
Annuals > 3 > balance Sheet > short Term Investments
347335
Annuals > 3 > balance Sheet > receivables
201784
Annuals > 3 > balance Sheet > inventories
38418
Annuals > 3 > balance Sheet > total Current Assets
6977516
Annuals > 3 > balance Sheet > property Plant Equipment
367949
Annuals > 3 > balance Sheet > total Assets
7833927
Annuals > 3 > balance Sheet > payables
25847
Annuals > 3 > balance Sheet > short Term Debt
85174
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
201437
Annuals > 3 > balance Sheet > equity
7948904
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-7383653
Annuals > 3 > cash Flow > depreciation
141315
Annuals > 3 > cash Flow > change In Working Capital
-351475
Annuals > 3 > cash Flow > cash From Operations
-4879339
Annuals > 3 > cash Flow > capital Expenditures
131448
Annuals > 3 > cash Flow > cash From Investing
-180640
Annuals > 3 > cash Flow > cash From Financing
-44600
Annuals > 3 > cash Flow > net Change In Cash
-5104579
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.2351778048322541
Annuals > 3 > ratios > PB
0.006737498591000722
Annuals > 3 > ratios > ROE
-91.4506452713481
Annuals > 3 > ratios > ROA
-92.79284833774938
Annuals > 3 > ratios > FCF
-5010787
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-19.619600073610886
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.13782981381784992
Valuation > metrics > PB
0.03336519148930477
Valuation > final Score
70
Valuation > verdict
96.7% Undervalued
Profitability > metrics > ROE
-90.17094374446641
Profitability > metrics > ROA
-77.7269273962077
Profitability > metrics > Net Margin
-15.49332183908046
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5259282127921324
Risk > metrics > Interest Coverage
-234.87350397484056
Risk > final Score
-891
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.540830185693648
Liquidity > metrics > Quick Ratio
2.540830185693648
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-151
Prev Risks > 1
-250
Prev Risks > 2
-173
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:08:03.971Z
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. Its DehydraTECH is used with a range of active molecules, including glucagon-like peptide-1 drugs (GLP-1) and glucose -dependent insulinotropic polypeptide drugs (GIP), vitamins, pain medications, hormones, phosphodiesterase type 5 (PDE5) inhibitors, antivirals, nicotine and its analogs, and cannabinoids. The company's DehydraTECH technology is applied to various therapeutic indications, such as diabetes, weight loss, hypertension, epilepsy, and heart disease; is implemented in a multitude of ingestible or topically administered product formats comprising oral suspensions, tablets, capsules, foods, beverages, and oral products; and is suitable for a variety of product formats, including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATreasury Yields: What is MSGSs 5 year growth outlook - Quarterly Performance Summary & Free Expert Verified Stock Movement Alerts baoquankhu1.vn
Read more →Buyback Watch: Is SHMD stock undervalued right now - Earnings Growth Report & Technical Confirmation Trade Alerts baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-08-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Lexaria Bioscience Corp
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-08-31)
(Last Updated 2025-08-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-08-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-08-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.